PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 75 filers reported holding PASSAGE BIO INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $329 | -30.1% | 500 | 0.0% | 0.00% | – |
Q2 2023 | $471 | -1.7% | 500 | 0.0% | 0.00% | – |
Q1 2023 | $479 | -30.6% | 500 | 0.0% | 0.00% | – |
Q4 2022 | $690 | -31.0% | 500 | 0.0% | 0.00% | – |
Q3 2022 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | – |
Q2 2022 | $1,000 | -50.0% | 500 | 0.0% | 0.00% | – |
Q1 2022 | $2,000 | -94.1% | 500 | -90.5% | 0.00% | – |
Q4 2021 | $34,000 | +580.0% | 5,283 | +956.6% | 0.00% | – |
Q3 2021 | $5,000 | -28.6% | 500 | 0.0% | 0.00% | – |
Q2 2021 | $7,000 | -22.2% | 500 | -28.6% | 0.00% | – |
Q3 2020 | $9,000 | – | 700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 4,959,769 | $15,375,000 | 15.35% |
HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,235,869 | $3,831,000 | 4.65% |
New Leaf Venture Partners, L.L.C. | 2,497,922 | $7,744,000 | 3.82% |
Frazier Life Sciences Management, L.P. | 5,009,219 | $15,529,000 | 1.32% |
Deep Track Capital, LP | 3,375,000 | $10,463,000 | 0.67% |
Orbimed Advisors | 7,331,999 | $22,729,000 | 0.37% |
Lynx1 Capital Management LP | 105,504 | $327,000 | 0.30% |
XTX Topco Ltd | 94,309 | $292,000 | 0.13% |
Woodline Partners LP | 1,913,880 | $5,933,000 | 0.10% |
GREAT POINT PARTNERS LLC | 113,900 | $353,000 | 0.08% |